105 related articles for article (PubMed ID: 22018894)
1. Experience with extracorporeal elimination therapy in myasthenia gravis.
Blaha M; Pitha J; Blaha V; Lanska M; Maly J; Filip S; Brndiar M; Langrova H
Transfus Apher Sci; 2011 Dec; 45(3):251-6. PubMed ID: 22018894
[TBL] [Abstract][Full Text] [Related]
2. A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis.
Köhler W; Bucka C; Klingel R
J Clin Apher; 2011 Dec; 26(6):347-55. PubMed ID: 22095647
[TBL] [Abstract][Full Text] [Related]
3. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
[TBL] [Abstract][Full Text] [Related]
4. Plasma exchange in elderly patients.
Basic-Jukic N; Brunetta B; Kes P
Ther Apher Dial; 2010 Apr; 14(2):161-5. PubMed ID: 20438537
[TBL] [Abstract][Full Text] [Related]
5. [Plasmapheresis in patients with myasthenia gravis].
Konishi T
Nihon Rinsho; 2008 Jun; 66(6):1165-71. PubMed ID: 18540364
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.
Jensen P; Bril V
J Clin Neuromuscul Dis; 2008 Mar; 9(3):352-5. PubMed ID: 18344718
[TBL] [Abstract][Full Text] [Related]
7. The treatment of severe forms of myasthenia gravis.
Iani C; Caramia M; Morosetti M; Loberti M; Palmieri MG; Meloni C; Gallucci MT; Casciani CU; Bernardi G
Funct Neurol; 1998; 13(3):231-7. PubMed ID: 9800150
[TBL] [Abstract][Full Text] [Related]
8. Periodic therapeutic plasma exchange in patients with moderate to severe chronic myasthenia gravis non-responsive to immunosuppressive agents: an eight year follow-up.
Triantafyllou NI; Grapsa EI; Kararizou E; Psimenou E; Lagguranis A; Dimopoulos A
Ther Apher Dial; 2009 Jun; 13(3):174-8. PubMed ID: 19527462
[TBL] [Abstract][Full Text] [Related]
9. [Favorable results of plasmapheresis in severe myasthenia gravis].
Blom RJ; Kuks JB; Westerterp-Maas A; Oosterhuis HJ
Ned Tijdschr Geneeskd; 1997 Feb; 141(8):381-4. PubMed ID: 9157298
[TBL] [Abstract][Full Text] [Related]
10. [Fundamental studies with respect to plasma exchange by using continuous-flow centrifuge system and the clinical trial in patients with myasthenia gravis].
Suga M; Akahonai Y; Tsujisaki M; Mori M; Yoshizaki H; Matsumoto H; Yachi A
Hokkaido Igaku Zasshi; 1982 Nov; 57(6):734-40. PubMed ID: 7183499
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group.
Gajdos P; Chevret S; Clair B; Tranchant C; Chastang C
Ann Neurol; 1997 Jun; 41(6):789-96. PubMed ID: 9189040
[TBL] [Abstract][Full Text] [Related]
12. Plasma exchange therapy for severe penicillamine-induced myasthenia gravis.
Lang AE; Humphrey JG; Gordn DA
J Rheumatol; 1981; 8(2):303-7. PubMed ID: 7230162
[TBL] [Abstract][Full Text] [Related]
13. [Plasmapheresis-pulse therapy in myasthenia gravis].
Jyoichi T; Noda Y; Mizuguchi M; Shimojo S; Miyahara T
Rinsho Shinkeigaku; 1988 Jan; 28(1):43-50. PubMed ID: 3383512
[No Abstract] [Full Text] [Related]
14. Safety of plasma exchange therapy in patients with myasthenia gravis.
Ebadi H; Barth D; Bril V
Muscle Nerve; 2013 Apr; 47(4):510-4. PubMed ID: 23322564
[TBL] [Abstract][Full Text] [Related]
15. [Immunoadsorption therapy for myasthenia gravis: study on the adsorption capacity of an immunoadsorption column].
Yeh JH; Chiu HC
J Microbiol Immunol Infect; 1999 Jun; 32(2):121-5. PubMed ID: 11565565
[TBL] [Abstract][Full Text] [Related]
16. Immunoadsorption in Guillain-Barré syndrome and myasthenia gravis.
Haupt WF; Rosenow F; van der Ven C; Birkmann C
Ther Apher; 2000 Jun; 4(3):195-7. PubMed ID: 10910018
[TBL] [Abstract][Full Text] [Related]
17. [In-vitro and in-vivo studies on the selective immunoadsorption treatment of neurological diseases].
Heininger K
Schriftenr Neurol; 1993; 33():1-91. PubMed ID: 8327864
[No Abstract] [Full Text] [Related]
18. Long-term treatment of myasthenia gravis with immunoadsorption.
Haas M; Mayr N; Zeitlhofer J; Goldammer A; Derfler K
J Clin Apher; 2002; 17(2):84-7. PubMed ID: 12210711
[TBL] [Abstract][Full Text] [Related]
19. Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A.
Szpirt W; Somnier F; Nielsen FC; Rødgaard A
Life Support Syst; 1985; 3 Suppl 1():351-5. PubMed ID: 3916613
[No Abstract] [Full Text] [Related]
20. Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosis.
Allen JA; Scala S; Jones HR
Muscle Nerve; 2010 Mar; 41(3):379-84. PubMed ID: 19918767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
